AU Stock MarketDetailed Quotes

CSL CSL Ltd

Watchlist
  • 282.265
  • +1.515+0.54%
20min DelayTrading Dec 27 12:18 AET
136.67BMarket Cap34.54P/E (Static)

CSL Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CSL Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 19, 20252025/H2-- / 7.217B--
Feb 11, 20252025/H1-- / 8.543B--
Aug 13, 20242024/H26.747B / 6.634B--
Feb 13, 20242024/H18.053B / 8.016B--
Aug 15, 20232023/H26.127B / 6.134B--
DatePeriodRevenue/EstimateEarnings Call
Aug 19, 20252025/H2-- / 7.217B--
Feb 11, 20252025/H1-- / 8.543B--
Aug 13, 20242024/H26.747B / 6.634B--
Feb 13, 20242024/H18.053B / 8.016B--
Aug 15, 20232023/H26.127B / 6.134B--

Unlock Free Earnings Estimates

CSL Ltd Earnings Reports

  • CSL Ltd: Results Presentation

    Aug 12 18:06 ET

  • CSL Ltd: Results Announcement

    Aug 12 18:05 ET

  • CSL Ltd: Full Year Statutory Accounts for 30 June 2024

    Aug 12 18:04 ET

  • CSL Ltd: Half Year Results Investor Presentation

    Feb 12 16:29 ET

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Rio Tinto Ltd
    RIO
    +1.04%
    Fortescue Ltd
    FMG
    +0.84%
    Westpac Banking Corp
    WBC
    +0.62%
    Woodside Energy Group Ltd
    WDS
    +0.62%
    National Australia Bank Ltd
    NAB
    +0.56%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Buy

    • Strong Buy

      66.67%

    • Buy

      13.33%

    • Hold

      20.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday+0.68%